Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04018339Phase 1Completed
Phase 1, randomised, double-blind trial in obesity comparing RTA 402 with Placebo (2 arms). Primary endpoints: Changes from baseline in weight at 6 months, Changes from baseline in fat mass at 6 months and 12 more. Started Aug 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04018339.